Dr. Jomnarong Lertsuwan

04 Mar 2022
Name: Dr. Jomnarong Lertsuwan
Office address: Research Laboratory of Immunology, Chulabhorn Research Institute,
54 Kamphaeng Phet 6 Talat Bang Khen, Lak Si, Bangkok 10210, Thailand
Tel: +662-5538555 ext. -, +6698-2674675 (mobile)
Fax: +662-553-8572
Positions: Researcher 1, Research Laboratory of Immunology, Chulabhorn Research Institute
E-mail: [email protected]
Website: https://research.cri.or.th/lab/immunology/
Research Interests
1. Autophagy and cell death
2. Purinergic signaling
3. Diabetes
Education and Degrees:
  • Khon Kaen University, 2003-2007
    B.S. Biology (First Class Honour), Khon Kaen University, Khon Kaen, Thailand, 2007
  • Center for Translational Cancer Research, University of Delaware, 2009-2014
    Ph.D., Biological Science, Laboratory for Cancer Ontogeny and Therapeutics, Center for Translational Cancer Research, Department of Biological Sciences, University of Delaware, USA, 2014

Research Positions

  • Researcher (2014-2018), Researcher 1 (2019-present), Chulabhorn Research Institute, Bangkok,

Professional Societies

  • Member: Science Society of Thailand, 2015-present


  • Intradepartmental Travel Award, The 2013 San Antonio Breast Cancer Symposium, 2013.
  • University Travel Award, The 2013 San Antonio Breast Cancer Symposium, 2013.
  • Intradepartmental Travel Award, Third International Inflammatory Breast Cancer Conference, 2012.

International Awards & Honours

  • First prize poster presentation award, International conference on Innovation in Cancer Research and Care, 2013
  • First prize of poster presentation, Chulabhorn Royal Academy International Conference, 2017

ORCID iD: https://orcid.org/0000-0002-5701-2382

Publications, 2017 – present or all times.

Research Articles in International Journals
1. Lertsuwan J, Svasti J, Satayavivad J. Adenosine Induces Autophagy in Cholangiocarcinoma Cells. Anticancer Res. 2021;41(8):3769-78.
2. Lertsuwan J, Sawasdichai A, Tasnawijitwong N, Gaston K, Jayaraman PS, Satayavivad J. Sequence of CX-4945 and Cisplatin Administration Determines the Effectiveness of Drug Combination and Cellular Response in Cholangiocarcinoma Cells In Vitro. Anticancer Res. 2021;41(12):6155-67.
3. Lertsuwan K, Phoaubon S, Tasnawijitwong N, Lertsuwan J. Adenosine Suppresses Cholangiocarcinoma Cell Growth and Invasion in Equilibrative Nucleoside Transporters-Dependent Pathway. Int J Mol Sci. 2020;21(3).
4. Kitchen P, Lee KY, Clark D, Lau N, Lertsuwan J, Sawasdichai A, et al. A Runaway PRH/HHEX-Notch3-Positive Feedback Loop Drives Cholangiocarcinoma and Determines Response to CDK4/6 Inhibition. Cancer Res. 2020;80(4):757-70.
5. Lertsuwan K, Nammultriputtar K, Nanthawuttiphan S, Phoaubon S, Lertsuwan J, Thongbunchoo J, et al. Ferrous and ferric differentially deteriorate proliferation and differentiation of osteoblast-like UMR-106 cells. Biometals. 2018;31(5):873-89.
6. Lertsuwan J, Lertsuwan K, Sawasdichai A, Tasnawijitwong N, Lee KY, Kitchen P, et al. CX-4945 Induces Methuosis in Cholangiocarcinoma Cell Lines by a CK2-Independent Mechanism. Cancers (Basel). 2018;10(9).
7. Lertsuwan K, Peters W, Johnson L, Lertsuwan J, Marwa I, Sikes RA. Purinergic Receptor Expression and Cellular Responses to Purinergic Agonists in Human Prostate Cancer Cells. Anticancer Res. 2017;37(2):529-37.
8. Lertsuwan J, Ruchirawat M. Inhibitory Effects of ATP and Adenosine on Cholangiocarcinoma Cell Proliferation and Motility. Anticancer Res. 2017;37(7):3553-61.


Share this